Newlink Genetics reported -7731000 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Agenus AGEN:US $ -35997000 20.08M
Bristol Myers Squibb BMY:US $ 3188M 399M
Capricor Therapeutics CAPR:US -6031530 2.85M
Celldex Therapeutics CLDX:US $ -23257000 2.92M
Eli Lilly And LLY:US $ 2569.9M 171.6M
Idera Pharmaceuticals IDRA:US $ -4182000 61K
Intrexon XON:US $ -17414000 3.07M
Merk MRK:US $ 5059M 207M
Nektar Therapeutics NKTR:US $ -115085000 2.17M
Newlink Genetics NLNK:US -7731000 1.16M
Pfizer PFE:US $ 9995M 4136M
Prothena PRTA:US -37944000 4.85M
Sarepta Therapeutics SRPT:US $ -86881000 18.93M
Vascular Biogenics VBLT:US -10564000 1.45M
YTE INCY:US $ 127.66M 7.71M